HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
A comprehensive and multidimensional program, the event brought together several speakers:
Multiple objectives to support our growth in Asia:
The webinar was a resounding success, attracting an engaged audience and generating lots of positive feedback. Well done to all the teams involved—Marketing, Sales, and Innovation—for this exemplary international collaboration, which contributes to HTL’s reputation!
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
HTL Biotechnology hosted a scientific summit in Chengdu, China, dedicated to PDRN/PN, bringing together more than 130 experts and professionals to discuss the latest scientific advances, regulatory developments and emerging applications.
Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.